Menu

Find clinical trials for Diabetes in Valencia, VC

CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones

Related conditions:

Diabetes Mellitus
Type 2 Diabetes Mellitus
Type 1 Diabetes Mellitus
Diabetic Foot
Foot Ulcer
Obesity
Ulcer
A woman searches for clinical trials

Diabetes trials near Valencia, VC, ESP:

The objective of DIAGNODE-3 is to evaluate the efficacy and safety of three intranodal injections of 4 μg of Diamyd compared to placebo, along with o...

Enrolling
Type 1 Diabetes Mellitus
Biological: Recombinant human glutamic acid decarboxylase (rhGAD65) formulated in Alhydrogel®
Biological: Placebo

Phase 3

Diamyd Medical

Valencia, Spain and 59 other locations

States, where 2 out of 3 non-traumatic amputations derive from diabetes. This is why the main objective of this project is to establish a st...

Invitation-only
Diabetic Foot
Other: Orthopedic intervention
University of Valencia

Valencia, Spain

This is a multicenter, randomized, placebo-controlled, 2-part study to evaluate the safety and efficacy of AT-001 in adult patients (N=675) with Diabetic...

Active, not recruiting
Diabetic Cardiomyopathies
Drug: AT-001
Drug: Placebo

Phase 3

Applied Therapeutics

Valencia, Spain and 78 other locations

This study will look at the long-term effects of semaglutide (active medicine) on diabetic eye disease when compared to placebo (dummy medic...

Active, not recruiting
Diabetes Mellitus, Type 2
Drug: Semaglutide
Drug: Placebo (semaglutide)

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 177 other locations

The purpose of the trial is to assess the efficacy and safety of tirzepatide to dulaglutide in participants with type 2 diabetes and increas...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Tirzepatide
Drug: Dulaglutide

Phase 3

Lilly
Lilly

València, Spain and 654 other locations

the effect of retatrutide on renal function in participants with overweight or obesity and chronic kidney disease (CKD), with or without Type 2 Diabetes...

Enrolling
Type 2 Diabetes
Overweight or Obesity
Drug: Placebo
Drug: Retatrutide

Phase 2

Lilly
Lilly

Valencia, Valenciana, Comunitat, Spain and 41 other locations

This study will look if CagriSema can lower kidney damage in people with chronic kidney disease (CKD), type 2 diabetes (T2D) and overweight ...

Enrolling
Type 2 Diabetes
Chronic Kidney Disease
Drug: Cagrilintide
Drug: Semaglutide

Phase 2

Novo Nordisk
Novo Nordisk

Valencia, Spain and 125 other locations

The main purpose of this study is to determine safety and efficacy of orforglipron compared with insulin glargine in participants with type 2 diabetes...

Active, not recruiting
Type 2 Diabetes
Chronic Kidney Disease
Drug: Orforglipron
Drug: Insulin Glargine

Phase 3

Lilly
Lilly

Alzira, Valenciana, Comunitat, Spain and 392 other locations

will be done in participants who have type 2 diabetes. Participants will take the study medicine together with the current diabetes...

Active, not recruiting
Type 2 Diabetes Mellitus
Drug: Placebo semaglutide
Drug: Semaglutide

Phase 3

Novo Nordisk
Novo Nordisk

Valencia, Spain and 347 other locations

of vamikibart administered intravitreally in participants with diabetic macular edema. Only one eye will be chosen as the study eye. The dur...

Active, not recruiting
Diabetic Macular Edema
Drug: Ranibizumab
Other: Sham Procedure

Phase 2

Roche
Roche

Burjassot, Valencia, Spain and 69 other locations